Transthyretin Silencing Therapies and the Cardiology Clinic: Selection, Cost and the Diagnostic Bottleneck Upstream. (2023). Journal of Heart and Cardiovascular Science, 4(1), 1-4. https://doi.org/10.5281/zenodo.22345291